Results 51 to 60 of about 53,338 (196)
Metalloproteases in Trypanosoma rangeli-infected Rhodnius prolixus [PDF]
Memórias do Instituto Oswaldo Cruz, 1999 Protease activities in the haemolymph and fat body in a bloodsucking insect, Rhodnius prolixus, infected with Trypanosoma rangeli, were investigated. After SDS-polyacrylamide gel electrophoresis containing gelatin as substrate, analysis of zymograms performed on samples of different tissues of controls and insects inoculated or orally infected with ...
Feder, D +3 more
openaire +4 more sources
Trypanosoma rangeli protein tyrosine phosphatase is associated with the parasite's flagellum
Memorias do Instituto Oswaldo Cruz, 2012 Protein tyrosine phosphatases (PTPs) play an essential role in the regulation of cell differentiation in pathogenic trypanosomatids. In this study, we describe a PTP expressed by the non-pathogenic protozoan Trypanosoma rangeli (TrPTP2).
Elisa Beatriz Prestes +9 more
doaj +1 more source
Memorias do Instituto Oswaldo Cruz, 2011 In America, there are two species of Trypanosoma that can infect humans: Trypanosoma cruzi, which is responsible for Chagas disease and Trypanosoma rangeli, which is not pathogenic. We have developed a model of vaccination in mice with T.
Vanina Marini +3 more
doaj +1 more source
Experimental Vaccines against Chagas Disease: A Journey through History
Journal of Immunology Research, Volume 2015, Issue 1, 2015., 2015 Chagas disease, or American trypanosomiasis, which is caused by the protozoan parasite Trypanosoma cruzi, is primarily a vector disease endemic in 21 Latin American countries, including Mexico. Although many vector control programs have been implemented, T. cruzi has not been eradicated. The development of an anti‐T.
Olivia Rodríguez-Morales +7 more
wiley +1 more source
Revista do Instituto de Medicina Tropical de São Paulo, 2007 Trypanosoma rangeli is non pathogenic for humans but of important medical and epidemiological interest because it shares vertebrate hosts, insect vectors, reservoirs and geographic areas with T. cruzi, the etiological agent of Chagas disease.
Paula Ximena Pavia +4 more
doaj +1 more source
Trypanosoma cruzi Infection and Host Lipid Metabolism
Mediators of Inflammation, Volume 2014, Issue 1, 2014., 2014 Trypanosoma cruzi is the causative agent of Chagas disease. Approximately 8 million people are thought to be affected worldwide. Several players in host lipid metabolism have been implicated in T. cruzi‐host interactions in recent research, including macrophages, adipocytes, low density lipoprotein (LDL), low density lipoprotein receptor (LDLR), and ...
Qianqian Miao +2 more
wiley +1 more source
Journal of Parasitology Research, Volume 2014, Issue 1, 2014., 2014 Trypanosoma evansi and Trypanosoma vivax, which are the major causative agents of animal trypanosomosis in Venezuela, have shown a very high immunological cross‐reactivity. Since the production of T. vivax antigens is a limiting factor as this parasite is difficult to propagate in experimental animal models, our goal has been to identify and isolate ...
Norma P. Velásquez +4 more
wiley +1 more source
Memorias do Instituto Oswaldo Cruz, 1984 The pathological effects of Trypanosoma rangeli on Rhodnius prolixus and R. robustus, and the relation of mortality to infection, were studied under laboratory conditions. Frequent observations revealed that when the first instar nymphs of R.
N. Añez
doaj +1 more source
, 2020 There is limited information about the innate immunity of triatomines against Trypanosoma rangeli, an infectious, non-pathogenic human parasite, and T. cruzi, the causative agent of Chagas’ disease. This study aimed at addressing this gap by studying the
Yazmin Suárez-Quevedo +8 more
semanticscholar +1 more source